Is Sunosi (solriamfetol) a controlled substance?
Medically reviewed by Drugs.com. Last updated on Aug 31, 2021.
Official Answer
by Drugs.comYes. Sunosi (solriamfetol) is a Schedule IV Controlled Substance in the United States.
Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). It was approved by the FDA in March 2019.
Sunosi is a federally controlled substance (CIV) because it contains solriamfetol, which has the potential for abuse.
Sunosi should always be stored in a safe place to protect it from theft. Any unused or expired Sunosi should be disposed of via a medication take-back program, or mixed with an undesirable substance and thrown away in the household trash.
Related Medical Questions
- Can you have narcolepsy and insomnia?
- What are the early signs of narcolepsy?
- What is the difference between narcolepsy and idiopathic hypersomnia?
- How do you test for narcolepsy?
- What is the treatment for narcolepsy?
Drug Information
Related Support Groups
- Sunosi (1 questions, 5 members)
- Solriamfetol (1 questions, 4 members)
- Narcolepsy (61 questions, 373 members)
- Obstructive Sleep Apnea/Hypopnea Syndrome (8 questions, 57 members)